INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 184 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $236,000 | -10.6% | 5,700 | +81.0% | 0.02% | -15.4% |
| Q2 2018 | $264,000 | -30.7% | 3,150 | 0.0% | 0.03% | -48.0% |
| Q2 2017 | $381,000 | +7.0% | 3,150 | 0.0% | 0.05% | +8.7% |
| Q1 2017 | $356,000 | +4.1% | 3,150 | 0.0% | 0.05% | +7.0% |
| Q4 2016 | $342,000 | -52.2% | 3,150 | -27.6% | 0.04% | -55.2% |
| Q3 2016 | $716,000 | +15.3% | 4,350 | 0.0% | 0.10% | +21.5% |
| Q2 2016 | $621,000 | +12.5% | 4,350 | +1.2% | 0.08% | +16.2% |
| Q1 2016 | $552,000 | -14.0% | 4,300 | 0.0% | 0.07% | -6.8% |
| Q4 2015 | $642,000 | – | 4,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |